|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Flecainide#Contraindications]] |
| {{Flecainide}}
| |
| {{CMG}}; {{AE}} {{SS}}
| |
| | |
| ==Contraindications==
| |
| | |
| Flecainide acetate is contraindicated in patients with pre-existing second- or third-degree AV block, or with right bundle branch block when associated with a left hemiblock (bifascicular block), unless a pacemaker is present to sustain the cardiac rhythm should complete heart block occur. Flecainide acetate is also contraindicated in the presence of cardiogenic shock or known hypersensitivity to the drug.
| |
| | |
| | |
| {|
| |
| |[[File:Flecainide01.jpg|thumb|800px]]
| |
| |}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = FLECAINIDE ACETATE TABLET [APOTEX CORP.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=72595783-e6a0-6b7a-f428-9ca03d707794#nlm34084-4 | publisher = | date = | accessdate = 11 March 2014 }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{Antiarrhythmic agents}}
| |
| | |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Piperidines]]
| |
| [[Category:Benzamides]]
| |
| [[Category:Phenol ethers]]
| |
| [[Category:Organofluorides]]
| |
| [[Category:Sodium channel blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Drugs]]
| |